ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,274.09
-0.18%
Dow Jones
38,603.60
0.08%
US Dollar vs MXN
17.80796
0.59%
Brent Oil
77.125
-1.30%
Bitcoin
69,688.01
1.28%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Shuttle Pharmaceuticals Holdings Inc (SHPH)

  7. Shuttle Pharmaceuticals Holdings Inc (SHPH) Noticias

SHPH Shuttle Pharmaceuticals Holdings Inc

0.5389
0.0009 (0.17%)
Última actualización: 09:29:09
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Shuttle Pharmaceuticals Holdings Inc SHPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0009 0.17% 0.5389 09:29:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.5199 0.5199 0.538999 0.538
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/5/202415:15EDGAR2Form 8-K - Current report
22/5/202415:15GLOBEShuttle Pharma to Participate in the Lytham Partners Spring..
14/5/202408:00EDGAR2Form 8-K - Current report
14/5/202408:00GLOBEShuttle Pharma Provides First Quarter 2024 Corporate Update
13/5/202416:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/4/202415:15GLOBEShuttle Pharmaceuticals to Present at the Planet MicroCap..
22/3/202408:00PRNUSShuttle Pharma Provides Fourth Quarter 2023 Corporate Update
08/3/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:00EDGAR2Form 8-K - Current report
13/2/202407:00EDGAR2Form 8-K - Current report
13/2/202407:00PRNUSShuttle Pharma Announces Its Intent to Pursue a Rights..
05/2/202415:25EDGAR2Form 8-K - Current report
23/1/202415:30PRNUSShuttle Pharma to Participate in a Fireside Chat at the..
08/1/202408:05EDGAR2Form 8-K - Current report
08/1/202408:00PRNUSShuttle Pharmaceuticals Receives FDA Approval to Proceed..
02/1/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202316:10EDGAR2Form 8-K - Current report
11/12/202308:00EDGAR2Form 8-K - Current report
11/12/202308:00PRNUSShuttle Pharmaceuticals Submits IND Application to the U.S...
30/11/202308:00EDGAR2Form 8-K - Current report
14/11/202308:00PRNUSShuttle Pharmaceuticals Provides Third Quarter 2023..
13/11/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202308:00PRNUSShuttle Pharma Advances Prostate Cancer Predictive Biomarker..
30/10/202316:14EDGAR2Form 8-K - Current report
20/10/202315:15EDGAR2Form ARS - Annual Report to Security Holders
20/10/202315:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202308:00EDGAR2Form 8-K - Current report
10/10/202308:00PRNUSShuttle Pharma to Participate in the Lytham Partners Fall..
05/10/202315:10EDGAR2Form 8-K - Current report
25/9/202308:00EDGAR2Form 8-K - Current report
25/9/202308:00PRNUSShuttle Pharma Announces Results of Pre-IND Meeting with FDA..
13/9/202308:00PRNUSShuttle Pharma Participates in Hampton University Proton..
11/9/202308:00PRNUSShuttle Pharma Expands Patent Coverage on HDAC Inhibitor..
07/9/202308:20EDGAR2Form 8-K - Current report
29/8/202308:00PRNUSShuttle Pharma's Selective HDAC6 Inhibitor Shown to..
24/8/202313:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/8/202318:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202308:00EDGAR2Form 8-K - Current report
15/8/202308:00PRNUSShuttle Pharmaceuticals Provides Second Quarter 2023..
14/8/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202308:00EDGAR2Form 8-K - Current report
03/8/202308:00PRNUSShuttle Pharmaceuticals Completes Manufacturing of Active..

Su Consulta Reciente

NASDAQ
SHPH
Shuttle Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados